Tuesday, November 12, 2019
- 9:00AM-11:00AM
-
Abstract Number: 2220
Abaloparatide Followed by Alendronate on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 9:00AM-11:00AM
-
Abstract Number: 2548
Abatacept Failed to Demonstrate Efficacy in an SLE Trial with Low Placebo Response Rates, Although Global Assessments Indicated Less Flare Severity
SLE – Clinical Poster III: Treatment- 9:00AM-11:00AM
-
Abstract Number: 2345
Abatacept in Rheumatoid Arthritis with Interstitial Lung Disease: A Retrospective Multicenter Study of 263 Patients
RA – Diagnosis, Manifestations, & Outcomes Poster III: Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 2029
Aberrant H3K9me3 Modification in Promoter Region Up-regulates cAMP Response Element Modulator Alpha in Systemic Lupus Erythematosus
SLE – Etiology & Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 2623
Abnormality of Percentages and Absolute Numbers of CD4+ Memory and Regulatory T Subset Cells in ANCA-associated Vasculitis
Vasculitis – ANCA-Associated Poster I- 9:00AM-11:00AM
-
Abstract Number: 2635
Accuracy of Self-Reported Diagnosis of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Vasculitis – ANCA-Associated Poster I- 9:00AM-11:00AM
-
Abstract Number: 2503
Achilles Tendon Enthesitis and Disease Burden in Psoriatic Arthritis and Axial Spondyloarthritis: Baseline Results from a Randomized Controlled Trial
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster III: Psoriatic Arthritis, Clinical Features- 9:00AM-11:00AM
-
Abstract Number: 2353
ACPA Testing and Resultant Treatment Patterns in Patients with Rheumatoid Arthritis: Findings from US Community Rheumatology Practices
RA – Treatments Poster III: Safety and Outcomes- 9:00AM-11:00AM
-
Abstract Number: 2082
Activity in Work and Life: The Association Between Physical Activity and Employment Status with Future Slow Walking in Knee Osteoarthritis
Epidemiology & Public Health Poster III: OA, Gout, & Other Diseases – ARP- 9:00AM-11:00AM
-
Abstract Number: 2133
Acute Myocardial Infarction in Rheumatoid Arthritis, Gout, and Osteoarthritis: A Retrospective Study Using the National Inpatient Sample from 2002-2016
Miscellanous Rheumatic & Inflammatory Disease Poster III: Autoimmune Conditions and Therapies- 9:00AM-11:00AM
-
Abstract Number: 2700
Adalimumab Alone Is Superior to Adalimumab Plus Methotrexate in Juvenile Idiopathic Arthritis Associated Uveitis: Data from the ORCHIDEA Registry
Pediatric Rheumatology – ePoster III: Systemic JIA, Fever, & Vasculitis- 9:00AM-11:00AM
-
Abstract Number: 1992
Adenosine A2A Receptor (A2AR) Stimulation Mitigates Mitochondrial Inflammaging, Enhances Mitochondrial Metabolism and Reduces Reactive Oxygen Species-Mediated Mitochondrial Injury In Vitro and In Vivo in Osteoarthritis
Osteoarthritis & Joint Biology – Basic Science Poster- 9:00AM-11:00AM
-
Abstract Number: 1967
Adenosine A2A Receptor Signals Through AMPK and SIRT1 to Increase Chondrocyte Homeostasis
Osteoarthritis & Joint Biology – Basic Science Poster- 9:00AM-11:00AM
-
Abstract Number: 2564
Adherence to Hydroxychloroquine Influences the Incidence of Organ Damage During Follow-up in Patients with Systemic Lupus Erythematosus
SLE – Clinical Poster III: Treatment- 9:00AM-11:00AM
-
Abstract Number: 2255
Adherence to Subcutaneous Anti-tnf Therapies in Chronic Inflammatory Rheumatism and Therapeutic Education